Phosphorylation levels of PRAS40 and MTOR were also upregulated after treatment with cabozantinib, although these changes did not reach statistical significance.
← all excerpts
RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation.
1
—
—